logo
Missed, misunderstood, and deadly: A Cape Town family's heartbreak with hepatitis B

Missed, misunderstood, and deadly: A Cape Town family's heartbreak with hepatitis B

Eyewitness News04-06-2025
Desmond Pedro was getting ready to attend a course at a college in Bellville in Cape Town when he noticed a hardness under his ribcage. The 30-year-old unemployed father of two small children hoped to learn skills on the government-sponsored boiler-making course.
The strange condition worried him. When Desmond first went to a clinic, nurses said it wasn't serious and gave him laxatives for constipation. He returned three times and got the same response.
On his fourth visit, Desmond's wife went with him, and she insisted on a scan. Two weeks later, while on his way to college, he returned to receive the results. His older brother, Mario tells the story: 'When he arrived, the clinic staff wouldn't let him leave. An ambulance took him to Tygerberg Hospital. We visited him that night but were told nothing. We felt helpless.'
About a week later, Desmond asked Mario to meet him at Tygerberg's oncology unit, where a doctor delivered the news of his diagnosis. 'When I arrived, he was in agony and couldn't stand up straight. This had all happened within two to three weeks. A porter brought a wheelchair, and we went into the doctor's office where the doctor told us hepatitis B had brought on Desmond's liver cancer.'
Hepatitis means that the liver is swollen or irritated. This can happen for many reasons, such as infections from viruses or bacteria, parasites, injuries, or when the body's immune system mistakenly attacks the liver. Viral hepatitis is a type of liver inflammation caused by a virus. There are five main types: A, B, C, D and E. As Spotlight previously reported, new, highly effective cures for hepatitis C are slowly becoming more widely available in South Africa.
WHERE DID IT COME FROM?
Until Desmond's cancer diagnosis, he had no idea that he was carrying the hepatitis B virus in his body, nor where he contracted it. The virus is transmitted from person to person through blood, semen or other body fluids. It can, for instance, be passed from pregnant women infected with the hepatitis B virus to their babies during childbirth, through sexual contact with an infected person, sharing of needles carrying traces of infected blood, and accidental needlestick injuries in health workers working with people who have the virus.
After Desmond's diagnosis, his entire family were tested. 'Both myself and my youngest brother, Johan tested positive for hepatitis B. To this day, we don't know where we got it or if we ever had the vaccine,' says Mario. 'At the time, I was 33. My mother was negative, as were our wives and all the children. For Desmond, it was too late.'
Once infected, some people have strong enough immune systems to fight off the infection and usually clear it within six months. This is called acute or short-term infection. People who get infected as adults normally have acute infections.
In long-term or chronic cases, it lasts more than six months and can lead to liver failure, liver cancer or cirrhosis – a condition where scar tissue has replaced healthy tissue to such an extent that the liver can no longer function. The younger a person is when they contract the virus, the higher their risk of the condition becoming chronic, particularly in the case of newborn babies or children under five. In most cases, people with chronic infection show no symptoms for years until they become seriously ill from liver disease.
A SILENT KILLER
One of the reasons that viral hepatitis can go undetected, as it did for Desmond, is that it is often asymptomatic. Symptoms, for those who do get them, can start as soon as two weeks after infection and include stomach pain, joint pain, fever, extreme fatigue, dark urine and jaundice – a yellowing of the skin and whites of the eyes.
Professor Mark Sonderup, Associate Professor in the Department of Medicine and Division of Hepatology at the University of Cape Town, explains that with chronic inflammation in the liver, the body's attempt to heal the inflammation drives scarring, or fibrosis, of the liver. Over ten, twenty or thirty years, he says, there's a serious risk of cirrhosis.
Sonderup says hepatitis B is endemic in South Africa and the region. He cites figures pegging the country's chronic infection rate at just below 5% which suggests there are in the region of three million people living with the infection in South Africa.
MOST CASES CAN BE TREATED
Chronic infection can usually be treated successfully with antiviral medicines if diagnosed in time. These medicines have to be taken for life since they suppress, but do not eliminate the virus. For acute infection there are much fewer treatment options. Those with serious liver damage often need a liver transplant.
Since their diagnosis, Mario and Johan have been going to the Groote Schuur Liver Clinic where he says they are in good hands. 'They've been there for us from the start,' says Mario.
The brothers are both on tenofovir, an anti-retroviral used to treat chronic hepatitis B infection. 'We take one tiny tablet a day, which suppresses our viral load and has no side effects. I take my tablet religiously at the same time every night.' Tenofovir is also part of standard HIV treatment in South Africa. As such, it is taken by more than five million people in the country, some of whom will happen to have undiagnosed hepatitis B infection.
Sadly, Desmond's diagnosis came too late for antiviral treatment to save him.
'I'll never forget the look on Desmond's face when the doctor said there was nothing they could do,' Mario recalls. 'The liver cancer was aggressive. He died at home about four weeks later. The time between getting his results and passing away was about two months.'
It is for this reason that Mario has become such a passionate advocate for hepatitis B testing. 'All it takes is a simple blood test, and if it's caught in time, you take one small tablet daily. There are no side effects and you're good to go,' he says. Mario reckons nurses testing for HIV should be testing for hepatitis B at the same time.
A HIGHLY EFFECTIVE VACCINE
One piece of good news is that many people in South Africa, especially those younger than 30 years of age, would have been vaccinated against the hepatitis B virus as babies.
The South African government began rolling out the vaccine in 1995, starting with a three-dose schedule for babies, administered at 6, 10, and 14 weeks.
'It took a while to reach full coverage across the entire country. To date, our numbers lag a little behind, in that full three dose coverage is somewhere in the mid 80 percent in South Africa,' says Sonderup. 'This is pretty decent, except that we do have babies born to women who are inadvertently chronically infected, and there's a full six-week period before the first dose of vaccine is given.'
In other words, there's a six-week gap before babies receive their first hepatitis B vaccine, leaving them unprotected during that time. This is why Sonderup recommends giving a vaccine birth dose within the first 24 hours after birth alongside the standard polio and BCG vaccines all newborns receive. 'This would be followed by the second, third and fourth doses at 6,10 and 14 weeks. This has been shown to completely shut down that potential six-week period where a baby may be exposed,' he says.
A PHASED APPROACH
Dr Kgomotso Vilakazi-Nhlapo, the top hepatitis official in the National Department of Health, agrees that a birth dose is important. However, she says that due to resource challenges, the department has opted for a phased approach.
According to Vilakazi-Nhlapo, this approach was implemented in April 2023 in all public health facilities but by the end of December 2024, they were only testing about 50% of pregnant women. 'This meant that women among the 50 percent who were not tested could be positive for hepatitis B and be transmitting the infection to their babies,' she says. 'Of course, it would be preferable to give a universal birth dose to all newborns, but, unfortunately, the budget and human resources remains an issue.'
Vilakazi-Nhlapo estimates that with around a million births per year and hepatitis B prevalence of around 5%, every year in the region of 50 000 women living with the virus are giving birth in South Africa.
WHAT TO DO
Sonderup says the solutions to South Africa's hepatitis B problem are neither complex nor overly expensive. 'Firstly,' he says, 'we need to fully implement the universal birth dose vaccination; secondly, we need to ensure children complete their vaccine schedule in total, thirdly we need to screen pregnant woman and link them to additional care.'
He also says that in a country where almost 5% of people are living with the virus, everyone should be screened for hepatitis B at least once as we do with regular HIV testing. 'This can be done through a simple finger prick test and it's not expensive. People should at least know their status,' Sonderup says.
South Africa's key hepatitis B policy document is the viral hepatitis treatment guidelines published in 2019. Sonderup, who was involved in the development of the guidelines, is concerned about its implementation. He blames 'policy inertia' and competition for limited resources for the country not having made greater progress against hepatitis B.
'But we can actually do a great deal with not very much, with significant impact, to eliminate a virus that continues to cause significant havoc,' he says.
'A SHORTAGE OF RESOURCES, STAFF AND SKILLS'
For her part, Vilakazi-Nhlapo blames a lack of 'resources, staff, and skills' for there not being more progress.
She says there is only one other person working with her on hepatitis at the national level, and no dedicated staff at provincial health departments. 'We work mainly with NGOs and civil society. Provincial physicians have helped us greatly to do our work but it's not enough,' Vilakazi-Nhlapo says.
'There is still insufficient knowledge both among healthcare workers and within communities about hepatitis B. For now, patients with hepatitis B are referred to hospitals … but the reality is that, if primary healthcare staff are managing HIV patients, they can manage hepatitis B patients,' she says. She adds that they are trying to integrate hepatitis into other health programmes, such as those for maternal and child health.
'EVERYONE SHOULD KNOW THEIR STATUS'
Back in Cape Town, Mario, now 45, says he feels healthy apart from the normal aches and pains associated with his age. He has become an advocate for more awareness about hepatitis B. 'We'd never have known we had it if this hadn't happened to my brother. It's a silent killer. Someone could be dying of it right now without knowing. Everyone should know their status,' he says.
This article first appeared on Spotlight. Read the original article here.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Dragon slayer — Dr Nomathemba Chandiwana battles obesity, ‘SA's new HIV epidemic'
Dragon slayer — Dr Nomathemba Chandiwana battles obesity, ‘SA's new HIV epidemic'

Daily Maverick

time4 minutes ago

  • Daily Maverick

Dragon slayer — Dr Nomathemba Chandiwana battles obesity, ‘SA's new HIV epidemic'

The obesity epidemic will hit South Africa hard on top of our high HIV burden, but advocate researcher and scientist Dr Nomathemba Chandiwana says she is ready to fight back harder. She speaks to Spotlight about her journey from working in state hospitals to transitioning into obesity medicine, and her move to Cape Town. For the briefest moment, Dr Nomathemba Chandiwana could have had a career in music – guitar in her arms, singing songs of being far from home but being lost in the best way possible. The chief scientific officer at the Desmond Tutu Health Foundation has carved out a career in public health for more than a decade. Her focus has been on HIV and, most recently, bringing insights from HIV research into tackling South Africa's high rates of obesity. But in her late teens, her undergrad years were spent at Northeastern in Boston, United States, pursuing a Bachelor of Science in behavioural neuroscience. Her degree included a guitar credit, and she spent hours wandering through museums. 'It was some of the best experiences of my life, really – because I could be just another kid in just another college town. I got to learn that life isn't just for learning, it's also for learning about life,' she tells Spotlight. It was perspective she needed so that by the time she enrolled at Wits Medical School in 2006 for her third degree, it wasn't to tick boxes of expectation of a kid who got good grades; the daughter of a prominent virologist and the graduate accepted to study medicine in the United States. She would learn another lesson about expectation when frontline medicine didn't turn out to be her career path after all. She was well into her journey of becoming a paediatrician and had worked as a medical officer at three state hospitals in Johannesburg, when she says a series of devastating public service strikes, culminating in tragedy in 2012, 'broke' her. A health system failing people Nurses couldn't come to work and there were deaths, she recalls. 'I was young, barely out of medical school and I was in charge of kids in high care. In one week, 12 babies passed … and one of the nurses was killed,' says Chandiwana. She adds: 'It was the health system that failed people; it wasn't the doctors and nurses. It was so clear to me that we have to fix the healthcare system.' Her move from healthcare provider to researcher began with joining Wits RHI – a leading research institute that specialises in HIV, TB, sexual and reproductive health, vaccines and infectious diseases. Here she worked in strengthening health systems, focused on maternal, child and adolescent health. She says arriving at public health research has been her 'happy place'. Chandiwana helped to write the chapter on HIV treatment in the National Strategic Plan (NSP) for HIV, TB and STIs 2023-2028 and contributed to treatment guidelines on tuberculosis and sexually transmitted infections such as syphilis. Working at Wits' Ezintsha Research Centre with Professor Francois Venter, among the foremost HIV research scientists in South Africa, Chandiwana was part of a team that conducted a landmark study that confirmed the safety and efficacy of HIV treatment that includes the antiretroviral drug dolutegravir. More than four million people in South Africa have since started taking dolutegravir-based HIV treatment. Raising the profile of African research 'This was African-led research and data. So you're helping your own people with real answers that they need – it's not research for research's sake,' she says. 'Less than 2% of research output is from Africa, yet we are the continent with one of the highest disease burdens from Covid-19, to TB, HIV and malaria,' she says. African researchers, she says, have real challenges compared with their Global North colleagues. She points out, for instance, some medical journals have publishing fees that run into the thousands of dollars – fees that are hard to pay given the very tight budgets most local researchers have to work with. 'If you're an African researcher, it's not like you're doing just research. You're probably writing the protocol, you're looking for funding, you are training and teaching,' she says. But Chandiwana also says difficulties build resilience and adaptability – she calls it 'Africa's spunk'. She adds that publishing should not, in any case, supersede the goal of conducting research that has real impact. Chandiwana goes as far as saying that publishing in high-impact research journals is great, but publishing in medium-impact journals is important too. And that's not where it ends, she says, adding that social media messaging also has its role. A growing threat Around 2018, some of the groundbreaking research that Chandiwana was involved with at Ezintsha demanded just such a wider audience. She and her colleagues were seeing a peculiar but clear correlation between people with HIV taking certain ARVs and gaining weight. Researchers are still figuring out to what extent this weight gain is due to people simply putting on pounds because the ARVs are helping them get healthier, and to what extent some ARVs might contribute to weight gain in other ways. It was an important finding, potentially affecting many of the more than six million people on HIV treatment in South Africa (there is a total of around eight million people in SA living with the virus). The picture is further complicated by the fact that South Africa's population of people living with HIV is ageing, and therefore at greater risk of developing conditions such as obesity and diabetes simply because they are living longer. In March 2024, Chandiwana and Venter wrote an editorial in the South African Medical Journal, calling obesity 'South Africa's new HIV epidemic'. The editorial warned that the lessons and missteps of the HIV response in the late 1990s and early 2000s should be a wake-up call for the country's response to fighting obesity. 'As with the HIV epidemic in the 1990s, we are facing a calamitous threat to the health of the population that has been ignored for too long,' they wrote. 'Weight-related diseases have eclipsed tuberculosis and HIV as leading causes of morbidity and mortality. Over two-thirds of South African women are overweight or are living with obesity,' they warned, citing that type 2 diabetes, stroke and heart disease are conditions all directly linked to obesity. 'They account for three of the top four causes of death nationally and incur massive health system costs,' they wrote. Chandiwana and Venter also slammed the sluggish response from a government which has not even now reined in industries that prop up ultra-processed food systems through policies or regulations. 'This is how I transitioned into obesity medicine,' says Chandiwana, who since the end of 2024 has been based at the Desmond Tutu Health Foundation in Cape Town, led by Professor Linda-Gail Bekker. She counts Venter and Bekker as the mentors and value-based leaders she admires. 'Obesity is the disease of our time' Chandiwana says obesity research is still a relatively new field. There is no specific formal training on obesity in local medical schools. As such, her work is intertwined with advocacy, shaping policy direction and putting planning in place to push for equitable access to new drugs, treatments and therapies for obesity. (Spotlight previously published an in-depth feature on the case for using breakthrough new weight loss medicines in South Africa.) 'Obesity is the disease of our time, all throughout the world. Every country in the world has got an obesity issue, but low- and middle-income countries are most affected. So we have to ask questions about the environment in which people live, the role of fast foods and ultra processed foods, the built environment, the levels of safety and security in neighbourhoods and how this impacts things like how people feel about exercising outdoors, their quality of sleep, and their access to places where they can access nutritious foods,' she says. The other strand in tackling obesity, she points out, is in the rise of a new class of type 2 diabetes drugs called glucagon-like-peptide-1 receptor agonists (GLP-1 RAs), increasingly also used to treat obesity. For instance, the diabetes medication Semaglutide can work to reduce appetite, help people feel fuller for longer and slow down gastric emptying, thereby promoting weight loss. (Spotlight previously published an article on which of the breakthrough weight loss medicines are available in South Africa and at what price.) These drugs are gamechangers, Chandiwana says. With treatment available, it means obesity can be seen and treated as a chronic metabolic disease. It helps to shed the stigma that obesity is simply an affliction caused by poor willpower and bad lifestyle choices. But the catch is the high price of the drugs, making questions about fair access to treatment top of mind for Chandiwana. As an HIV physician and research advocate, there are many parallels Chandiwana draws about these new drugs and ARVs in the early days of getting treatment to people living with HIV. Ultimately, it's about who gets left behind. And once again, even in the case of obesity in South Africa, she says it's black women most at risk. 'My research interest is therefore also about how to make sure we have comprehensive treatment plans that include looking at environment, food and lifestyle. Everyone should be allowed to increase not just their lifespan but their health-span, including through access to antiretrovirals, anti-obesity drugs, diabetic drugs or hypertension drugs,' she says. Putting people at the heart of research Chandiwana says her research approach is shaped by community strategies, building advocacy and training others, and locally appropriate solutions and interventions. One project Chandiwana highlights is the work the Desmond Tutu Health Foundation does at the Mpilo Health Park in Masiphumelele, Cape Town. It is where youth can access sexual and reproductive health services and also use an on-site gym and sports grounds. The idea is that combining services means looking to more holistic interventions to improve health, wellbeing and even access to secure recreational spaces for young people. 'There is no research without communities. They are the people who say 'yes' to being part of research – yes, they'll help us find answers. It is not researchers doing it by themselves,' she says. Chandiwana is intentional about putting people at the heart of research. She says people know what works best for them ultimately and people, when they're heard, can sway governments. 'As a researcher, I believe I am a storyteller. Research is not something abstract or just about the data, for me it's people's stories that I am telling,' says Chandiwana. Falling in love with Cape Town Her own story has seen her become a Capetonian. It was unexpected, she says, and so was becoming a Capetonian with a dog who enjoys going on long hikes, she jokes. But the die-hard ex-Joburger admits to falling in love with Cape Town more deeply each day. It's home now for her, husband Zviko Mudimu, their two children and nanny Thembi Ndlovu. 'I was one of those people who said I could never live in Cape Town,' Chandiwana says of the city's notoriously blatant racial and wealth divides. 'One of the things I remind myself of in Cape Town is that I might be pushing in spaces that I've been told are not meant for me. I have to remind myself that it's my country too, and I am allowed. Some things about Cape Town do need a shake-up,' she says. She calls for dragon slayers in a time of dragons – drawing an analogy from her soft spot for high fantasy and science fiction. But she also admits that Cape Town has made her check her assumptions and expectations. It's surprised and shaken her, too. Reciprocal action, after all, can be how change is made. And change in the right direction is what keeps her going, or as she puts it on her WhatsApp status, to 'chop wood, carry water'. Chandiwana adds: 'The whole point of the work we do is that we believe we're leaving our corner of the world a little better off. Sometimes it's about pushing back, becoming a bigger advocate, and working with imperfect allies. In the end, it's about finding more ways to walk this road we're on.' DM

National convention set
National convention set

eNCA

time12-08-2025

  • eNCA

National convention set

JOHANNESBURG - The National Dialogue has become contentious before it has begun. WATCH: National dialogue | Transparency and costs spark debate Last week the Thabo Mbeki, Desmond and Leah Tutu, Steve Biko and FW de Klerk foundations withdrew from the National Dialogue Task Team and the National Convention which is the first major event planned for this Friday. We've heard from the President and the new team steering the event on Friday saying it will go ahead. One of the contentious issue is costs. Nonkululekho Mtambo from the National Convention Organising Committee discussed this with eNCA.

Trailblazer at 74: Princess Anne-Sheilah Makhado's inspiring journey in nursing and advocacy
Trailblazer at 74: Princess Anne-Sheilah Makhado's inspiring journey in nursing and advocacy

Daily Maverick

time11-08-2025

  • Daily Maverick

Trailblazer at 74: Princess Anne-Sheilah Makhado's inspiring journey in nursing and advocacy

With humour, warmth and steely resolve, Princess Anne-Sheilah Makhado speaks to Spotlight about her long journey as a nurse, of creating solutions in the public health system, and her burning passion for motivating women and girls to unlock their talents. Princess Anne-Sheilah Makhado has worn many hats: that of midwife, professional nurse, motivational speaker, farmer, seamstress, mother and author. Her latest achievement was graduating last year with a PhD in advanced nursing science from the University of Venda at the age of 74. And Makhado is still learning. She recently returned home to Louis Trichardt in Limpopo armed with fresh insight after a month in Beijing visiting her son, who is teaching English in China. 'In China, I observed a lot,' she says. 'It's peaceful and very clean. I've never seen such beautiful red roses right in town, and no one steals these roses. And the elderly there, no one I saw was limping; people are working and they have purpose.' Reflecting on this, she recalls telling her group of retirees in Louis Trichardt that if they want to stay healthy, they need to make an effort to exercise more and keep busy. Keeping busy has been a hallmark of Makhado's life. Fittingly, she describes herself as 'results oriented' and 'thirsty'. She adds: 'I ask God to send me where there is a need.' Makhado's competing priorities came to a head in 2015, when she applied for a Master of Nursing course at the University of Venda. She was 65 at the time. 'The dean said: 'I can't take you' and I said: 'Why?' And she said: 'You got 59.8 marks for your Honours degree.'' This is just below the 60% minimum typically required to qualify for a Master's programme. Looking back, Makhado explains that during her Honours studies, which she completed in 2010, she was also juggling a demanding role as nursing services manager at Midlands Provincial Hospital in Graaff-Reinet, a position she held for six years. 'I had been running an institution where I found nursing issues to not be up to a good standard,' she recalls. The rejection hit hard. 'I cried then, I cried like a baby,' she says. 'Then in 2017, I went back to the university, and I said: 'I am back to repeat my Honours now'.' She completed the degree a second time, earning her graduation in 2018. That same year, she enrolled for her Master's, which she completed in 2020. Child-headed households Her Master's research, which focused on the experiences of child-headed households, was inspired by her work with a non-profit organisation she founded in 2018 called Voice of the Voiceless. Building on this, her PhD explored strategies to improve support for these children. She interviewed 15 child heads of households, aged 14 to 19, along with 15 of their relatives, and conducted additional focus group discussions within the community. 'Many of these children, when asked about their parents, would say: 'We heard that our mother died but we're not sure when, we don't even have a picture of our mum.' And many of them didn't know their father,' she says. A key finding in Makhado's research was a need to educate men around family values. 'That's why, in my recommendations, I said there should be man-to-man programmes because men are [conceiving] children and leaving the children there. Men must learn to take care of their children. Not just dump the mother with the baby. Then the mother has HIV and dies — and the children?' Another key recommendation was that traditional leaders should play a greater role in caring for orphaned children. 'I went to the traditional leaders, and I said: 'You are a traditional leader. What are you doing for these children? You need to have a list of the children who are heading families in your area, and you must visit them.'' With high crime rates, alcohol and drug use, and some child-headed homes unable to secure their doors, Makhado also questioned the role of the community policing forum. '[A]re they aware that these children must be protected and kept safe? The drug sellers know there are no parents and know they can abuse these kids.' Reflecting on conditions in these communities, she says: 'It is painful my darling, traumatic.' From Sophiatown to Limpopo and Chris Hani Baragwanath Hospital Makhado grew up in a tightly-knit family. The second born of seven siblings, soon after her birth in Johannesburg's Sophiatown in 1950, the family moved to Sibasa in Limpopo where her father worked for the then Native Affairs Department and her mother was a school teacher. 'My mother was so neat and clean and organised,' she says. 'My mother taught us never to take no for an answer and to never settle for less.' After attending Shingwedzi Secondary School, she trained and worked first as a teacher, then as a typist. But one day entering a hospital, she recalls: 'I saw the crisp white uniforms, my heart bled and I knew this is what I wanted.' At 27, she started her Diploma in Nursing at the then Groothoek Nursing College in Polokwane, moving to Chris Hani Baragwanath Hospital in Soweto to specialise in midwifery. She says her first job as a nursing sister in Baragwanath's buzzing casualty and neurology sections was 'wonderful, really'. Chuckling, Makhado recalls how one patient grew so enamoured with her, that she suggested Makhado marry her brother: 'So the guy was invited to come and meet me. But he was a short guy and I was not interested in short guys.' How does one become a good nurse? 'Nursing starts with you,' she says. 'The question is: 'How would you like to be treated when you are ill?'' In 1984, Makhado moved back to Limpopo to Elim Hospital and then to the former Transvaal Provincial Hospital — which is now the Louis Trichardt Memorial Hospital — as a clinic sister supervisor, with tasks including managing mobile clinics in the area. 'Working directly with the vulnerable and disadvantaged, women working on farms from a tender age, carrying their babies, I felt a strong need to empower them,' she says. Another issue close to her heart is children with special needs. In 1998, Makhado says she helped set up Tshilwavhusiku Razwimisani, a special needs school for children 25km outside of Louis Trichardt. 'I used to visit schools in that area and picked up so many children who had some type of disability.' As a results-orientated person, she says she couldn't turn a blind eye to this. 'So we sat down and identified an area where we could start a school for the mentally challenged.' Makhado says Tshilwavhusiku Razwimisani started with just 30 pupils and volunteers, including mothers preparing meals. Today, the provincial education department is running the school, which has 298 learners. 'There are moments where I feel like crying. We started from nothing,' she says. Training nurses in Graaff Reinet In 2008, Makhado became the nursing services manager at Midlands Provincial Hospital in Graaff Reinet, in the Eastern Cape. 'There was a lot of unemployment, and many young people would say to me they wanted to do nursing,' she says. But the challenge was the nursing colleges were far away in Mthatha or Gqeberha. The solution came to her: starting a nursing training college at the hospital. 'So I applied to the South African Nursing Council in 2010. Oh, and God has been wonderful, the college was approved in 2012. The next challenge was, where do I get the structures where the school would operate?' Makhado says she then negotiated with the provincial Department of Public Works to renovate buildings for student nurses' accommodation, and with the then mayor of Camdeboo Local Municipality, Hanna Makoba, to secure classrooms. 'I used to go out to furniture shops and ask for whatever furniture… for the nurses,' she recalls. This would become the Midlands Hospital Nursing School, today still an accredited institution within the Eastern Cape health system. During our interview, she checks the spelling of Makoba's name on her phone, saying they have kept in touch. The Master Lock Key Upon retiring from the public sector at Midlands Hospital in 2013, Makhado returned to Louis Trichardt where she focused on motivational speaking, continuing her community outreach work and studies. She also wrote a book called The Master Lock Key. 'It has been and will always be in my deepest innermost thoughts that women are the backbone of the nation. If women can learn to stand firmly in great numbers and become more assertive in issues that concern themselves, their families and the nation, I believe there will be a better future,' she wrote. Makhado is divorced and a mother of three children: two daughters and a son, and three grandchildren. When she struggled to make ends meet on a nursing salary, she says she sewed for extra income. 'My mother, when we grew up, she used to show us how to sew. She gave me that skill. So when times were tough, I did some sewing. I used to produce track suits for schools. When I came back from working as a nurse, I would take out my sewing machines.' Makhado relays how farming and growing food has been another enduring joy. Presently, she heads gardening projects that supply the Spar in Louis Trichardt with spinach, beetroot and garlic. 'It's quite amazing,' she says. 'I encourage all, I urge women and girls, let us work and fight poverty and hunger instead of idleness and being dependent. Women have this dependency syndrome. I said: 'Oh no, we cannot go on like this!'' As our conversation draws to a close, Makhado underscores South Africa's need for women leaders, saying that 'anything is within a woman's power'. She adds: 'This country needs women's listening ears and caring touch, but also thinkers, risk takers. Risk is the spice of life. What we women can achieve is virtually limitless.' DM

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store